Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diethylstilbestrol | 16 | 2011 | 51 | 1.230 |
Why?
|
| Prenatal Exposure Delayed Effects | 14 | 2011 | 154 | 0.820 |
Why?
|
| Estrogens, Non-Steroidal | 12 | 2011 | 38 | 0.750 |
Why?
|
| Vaginal Smears | 5 | 2008 | 59 | 0.690 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2008 | 150 | 0.550 |
Why?
|
| Maternal Exposure | 4 | 2009 | 42 | 0.460 |
Why?
|
| Gynecology | 3 | 2007 | 55 | 0.360 |
Why?
|
| Papillomaviridae | 3 | 2006 | 59 | 0.340 |
Why?
|
| Papillomavirus Infections | 3 | 2007 | 133 | 0.310 |
Why?
|
| Obstetrics | 2 | 2007 | 88 | 0.280 |
Why?
|
| Maternal Welfare | 1 | 2008 | 15 | 0.270 |
Why?
|
| Menopause | 2 | 2008 | 256 | 0.270 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2008 | 55 | 0.260 |
Why?
|
| Women's Health Services | 1 | 2007 | 30 | 0.260 |
Why?
|
| Cervix Uteri | 2 | 2006 | 58 | 0.240 |
Why?
|
| Environmental Exposure | 1 | 2008 | 223 | 0.240 |
Why?
|
| Attitude to Health | 1 | 2008 | 296 | 0.230 |
Why?
|
| Smoking | 2 | 2008 | 860 | 0.230 |
Why?
|
| Viral Vaccines | 1 | 2006 | 55 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2007 | 224 | 0.220 |
Why?
|
| Vulvar Diseases | 1 | 2004 | 5 | 0.220 |
Why?
|
| Breast Neoplasms | 7 | 2011 | 1214 | 0.220 |
Why?
|
| Ovarian Neoplasms | 2 | 2005 | 165 | 0.210 |
Why?
|
| Women's Health | 1 | 2007 | 374 | 0.210 |
Why?
|
| Uterine Cervical Diseases | 1 | 2002 | 4 | 0.190 |
Why?
|
| Pregnancy | 17 | 2011 | 2363 | 0.190 |
Why?
|
| Vaccination | 1 | 2006 | 374 | 0.190 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2002 | 80 | 0.180 |
Why?
|
| Physician's Role | 1 | 2002 | 122 | 0.170 |
Why?
|
| Female | 28 | 2011 | 33765 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 4 | 2007 | 726 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2003 | 705 | 0.140 |
Why?
|
| Adult | 18 | 2010 | 17243 | 0.140 |
Why?
|
| Colposcopy | 3 | 2006 | 20 | 0.120 |
Why?
|
| Humans | 28 | 2011 | 64778 | 0.120 |
Why?
|
| United States | 10 | 2009 | 8051 | 0.100 |
Why?
|
| Follow-Up Studies | 9 | 2011 | 2483 | 0.100 |
Why?
|
| Middle Aged | 14 | 2010 | 18112 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 18 | 0.090 |
Why?
|
| Risk | 4 | 2009 | 376 | 0.090 |
Why?
|
| Mass Screening | 2 | 2009 | 696 | 0.080 |
Why?
|
| Surveys and Questionnaires | 9 | 2010 | 2751 | 0.080 |
Why?
|
| Adolescent | 5 | 2008 | 6292 | 0.080 |
Why?
|
| Urogenital Abnormalities | 1 | 2009 | 12 | 0.080 |
Why?
|
| Cohort Studies | 7 | 2010 | 2603 | 0.070 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2011 | 29 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2007 | 32 | 0.070 |
Why?
|
| Vaginal Neoplasms | 1 | 2008 | 4 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 239 | 0.070 |
Why?
|
| Behavior | 1 | 2008 | 36 | 0.070 |
Why?
|
| Papanicolaou Test | 1 | 2008 | 46 | 0.070 |
Why?
|
| Sex Ratio | 1 | 2007 | 10 | 0.070 |
Why?
|
| Physical Examination | 1 | 2008 | 110 | 0.070 |
Why?
|
| Insurance, Liability | 1 | 2007 | 2 | 0.070 |
Why?
|
| Liability, Legal | 1 | 2007 | 19 | 0.070 |
Why?
|
| DNA, Viral | 2 | 2005 | 231 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2008 | 160 | 0.060 |
Why?
|
| Growth Substances | 1 | 2007 | 34 | 0.060 |
Why?
|
| Immunization Programs | 1 | 2007 | 14 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 383 | 0.060 |
Why?
|
| Preventive Medicine | 1 | 2007 | 25 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2007 | 73 | 0.060 |
Why?
|
| Hormones | 1 | 2007 | 62 | 0.060 |
Why?
|
| Age Factors | 2 | 2008 | 1580 | 0.060 |
Why?
|
| Estradiol Congeners | 1 | 2006 | 2 | 0.060 |
Why?
|
| Carcinogens | 1 | 2006 | 33 | 0.060 |
Why?
|
| Endocrine Disruptors | 1 | 2007 | 78 | 0.060 |
Why?
|
| Menstruation Disturbances | 1 | 2006 | 18 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 74 | 0.060 |
Why?
|
| Immunization Schedule | 1 | 2006 | 22 | 0.060 |
Why?
|
| Career Choice | 1 | 2007 | 132 | 0.060 |
Why?
|
| Papillomavirus Vaccines | 1 | 2007 | 70 | 0.060 |
Why?
|
| Hypospadias | 1 | 2005 | 3 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2005 | 58 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2007 | 299 | 0.060 |
Why?
|
| Ultrasonic Therapy | 1 | 2004 | 9 | 0.060 |
Why?
|
| Neuromuscular Agents | 1 | 2004 | 16 | 0.050 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2004 | 16 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 364 | 0.050 |
Why?
|
| Program Development | 1 | 2006 | 208 | 0.050 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2004 | 19 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 2005 | 36 | 0.050 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2004 | 20 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2006 | 194 | 0.050 |
Why?
|
| DNA Probes, HPV | 1 | 2004 | 3 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 2005 | 197 | 0.050 |
Why?
|
| Nuclear Family | 3 | 2009 | 18 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2006 | 489 | 0.050 |
Why?
|
| Physician-Patient Relations | 2 | 2008 | 427 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2006 | 270 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2003 | 140 | 0.050 |
Why?
|
| Cell Biology | 1 | 2002 | 22 | 0.050 |
Why?
|
| Progestins | 1 | 2002 | 29 | 0.050 |
Why?
|
| Patient Care | 1 | 2002 | 77 | 0.050 |
Why?
|
| Proportional Hazards Models | 3 | 2009 | 734 | 0.040 |
Why?
|
| Estrogens | 1 | 2002 | 116 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2003 | 191 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2003 | 211 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2009 | 755 | 0.040 |
Why?
|
| Postmenopause | 1 | 2002 | 238 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 2091 | 0.040 |
Why?
|
| Risk Factors | 5 | 2010 | 5399 | 0.040 |
Why?
|
| Male | 8 | 2009 | 30812 | 0.040 |
Why?
|
| Neoplasms | 1 | 2008 | 1357 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2007 | 1411 | 0.020 |
Why?
|
| Aged | 2 | 2005 | 14840 | 0.020 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2011 | 11 | 0.020 |
Why?
|
| Incidence | 2 | 2006 | 1410 | 0.020 |
Why?
|
| Stillbirth | 1 | 2011 | 18 | 0.020 |
Why?
|
| Menopause, Premature | 1 | 2011 | 25 | 0.020 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2009 | 14 | 0.020 |
Why?
|
| Young Adult | 2 | 2010 | 4773 | 0.020 |
Why?
|
| Cryptorchidism | 1 | 2009 | 20 | 0.020 |
Why?
|
| Gestational Age | 1 | 2009 | 195 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2006 | 3299 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2008 | 12 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 2008 | 5 | 0.020 |
Why?
|
| Leukemia | 1 | 2008 | 61 | 0.020 |
Why?
|
| Medical Records | 1 | 2008 | 139 | 0.020 |
Why?
|
| American Cancer Society | 1 | 2007 | 3 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2007 | 25 | 0.020 |
Why?
|
| Child | 2 | 2008 | 4601 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2009 | 302 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 83 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 346 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2006 | 47 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2008 | 365 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2007 | 344 | 0.010 |
Why?
|
| Cell Division | 1 | 2007 | 448 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 259 | 0.010 |
Why?
|
| Ovarian Cysts | 1 | 2005 | 4 | 0.010 |
Why?
|
| Leiomyoma | 1 | 2005 | 18 | 0.010 |
Why?
|
| Cytodiagnosis | 1 | 2004 | 46 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 134 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2005 | 529 | 0.010 |
Why?
|
| Reproductive History | 1 | 2002 | 17 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2006 | 405 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1274 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 2049 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 694 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1689 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1159 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 1268 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 6811 | 0.010 |
Why?
|
| Animals | 1 | 2010 | 21310 | 0.010 |
Why?
|